Cart summary

You have no items in your shopping cart.

Anti-Trop2 (sacituzumab biosimilar) mAb

Catalog Number: orb689328

DispatchUsually dispatched within 5-10 working days
$ 170.00
Catalog Numberorb689328
CategoryAntibodies
DescriptionAnti-Trop2 (sacituzumab biosimilar) mAb
Species/HostHuman Humanized
ClonalityMonoclonal
Tested applicationsELISA, FC
ReactivityHuman
IsotypeIgG1
Antibody TypeBiosimilar Antibody
Dilution rangeELISA 1:5000-10000; Flow Cyt 1:100
Form/AppearancePowder
PurityPurified from cell culture supernatant by affinity chromatography
ConjugationUnconjugated
TargetTrop2
UniProt IDP09758
StorageMaintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Buffer/PreservativesLyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization.
Alternative namesTACSTD2;GA733-1;M1S1;TROP2
Read more...
NoteFor research use only
Application notesLyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution.
Expiration Date12 months from date of receipt.
Anti-Trop2 (sacituzumab biosimilar) mAb

ELISA plate pre-coated by 2 μg/ml (100 μL/well) Human Trop2, mFc-His tagged protein orb689477 can bind Anti-Trop2 Neutralizing antibody in a linear range of 0.13-16.0 ng/ml.

Anti-Trop2 (sacituzumab biosimilar) mAb

Flow cytometry analysis of antigen binding of anti-human Trop2 mAb (orb689328). (A) orb689328 does not bind to 293T cells that do not express Trop2. (B) A clear peak shift of orb689328 was seen compared to the control when incubated with Trop2-expressing A431 cells, indicating strong binding of orb689328 to Trop2. Antibodies were incubated at 2 μg/mL.

Anti-Trop2 (sacituzumab biosimilar) mAb

HEK293 cell line transfected with irrelevant protein (B) and human Trop2 protein (A) were surface stained with anti-Trop2 neutralizing antibody 1 μg/ml (sacituzumab) followed by Alexa 488-conjugated anti-human IgG secondary antibody.